AIkido Pharma Inc.
Index- P/E- EPS (ttm)-1.28 Insider Own4.33% Shs Outstand5.25M Perf Week11.21%
Market Cap32.38M Forward P/E- EPS next Y-2.21 Insider Trans0.00% Shs Float5.03M Perf Month24.04%
Income-6.70M PEG- EPS next Q-0.68 Inst Own8.00% Short Float1.19% Perf Quarter-19.11%
Sales- P/S- EPS this Y80.20% Inst Trans-5.90% Short Ratio0.53 Perf Half Y-40.68%
Book/sh18.10 P/B0.35 EPS next Y38.10% ROA-6.30% Target Price34.00 Perf Year-60.16%
Cash/sh13.24 P/C0.47 EPS next 5Y- ROE-6.70% 52W Range4.30 - 17.17 Perf YTD-37.37%
Dividend- P/FCF- EPS past 5Y-14.90% ROI- 52W High-62.84% Beta1.41
Dividend %- Quick Ratio110.80 Sales past 5Y- Gross Margin- 52W Low48.37% ATR0.37
Employees4 Current Ratio110.80 Sales Q/Q- Oper. Margin- RSI (14)64.48 Volatility6.03% 7.15%
OptionableNo Debt/Eq0.00 EPS Q/Q39.80% Profit Margin- Rel Volume0.41 Prev Close6.25
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume113.86K Price6.38
Recom2.00 SMA2013.98% SMA5015.19% SMA200-29.98% Volume8,746 Change2.08%
Jun-28-22 09:00AM  
Jun-24-22 09:00AM  
Jun-21-22 04:30PM  
Jun-10-22 04:15PM  
Jun-07-22 04:30PM  
Jun-03-22 04:30PM  
May-19-22 08:30AM  
May-12-22 03:40PM  
May-11-22 07:10AM  
May-05-22 09:45AM  
May-04-22 03:29PM  
Apr-22-22 10:00AM  
Apr-05-22 02:00PM  
Mar-11-22 10:00AM  
Mar-08-22 01:30PM  
Mar-03-22 10:00AM  
Mar-02-22 05:09PM  
Feb-25-22 08:00AM  
Jan-24-22 01:30PM  
Jan-05-22 10:00AM  
Dec-14-21 10:00AM  
Dec-06-21 10:00AM  
Dec-02-21 04:24AM  
Nov-12-21 09:50AM  
Sep-28-21 10:45AM  
Sep-20-21 09:00AM  
Sep-14-21 09:22AM  
Aug-06-21 10:00AM  
Jul-27-21 10:00AM  
Jul-16-21 10:00AM  
Jul-13-21 10:00AM  
Jun-23-21 10:00AM  
Jun-05-21 03:16AM  
Jun-04-21 09:00AM  
May-20-21 03:24PM  
May-19-21 08:30AM  
May-13-21 09:00AM  
May-12-21 09:00AM  
May-11-21 09:00AM  
May-06-21 07:00AM  
Apr-27-21 10:00AM  
Apr-26-21 09:00AM  
Apr-22-21 09:00AM  
Apr-16-21 10:00AM  
Apr-07-21 09:00AM  
Apr-05-21 09:00AM  
Mar-29-21 09:00AM  
Mar-12-21 10:00AM  
Mar-04-21 09:00AM  
Mar-01-21 09:00AM  
Feb-23-21 10:56AM  
Feb-22-21 09:00AM  
Feb-19-21 11:10AM  
Feb-16-21 10:15PM  
Feb-03-21 09:00AM  
Feb-02-21 09:00AM  
Feb-01-21 08:00AM  
Jan-22-21 01:30PM  
Jan-11-21 08:30AM  
Jan-06-21 08:00AM  
Dec-09-20 10:00AM  
Nov-20-20 08:00AM  
Nov-13-20 09:00AM  
Nov-08-20 07:38AM  
Oct-28-20 01:30PM  
Sep-18-20 10:00AM  
Sep-11-20 10:00AM  
Aug-31-20 05:00PM  
Aug-18-20 09:00AM  
Aug-14-20 09:00AM  
Aug-11-20 10:00AM  
Aug-05-20 09:00AM  
Aug-03-20 10:00AM  
Jul-09-20 01:31PM  
Jun-26-20 10:30AM  
May-28-20 10:00AM  
May-19-20 10:00AM  
May-08-20 05:00PM  
May-06-20 01:30PM  
May-04-20 05:00PM  
Apr-30-20 02:33PM  
Apr-21-20 08:30AM  
Apr-20-20 08:30AM  
Apr-15-20 01:41PM  
Apr-14-20 12:08PM  
Mar-27-20 05:30PM  
Mar-26-20 10:15AM  
Mar-23-20 08:00PM  
Mar-18-20 12:52PM  
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.